The present investigation was undertaken to compare the structural and electronic properties of genipin with those of tetrahydrobiopterin (H 4 B), an essential cofactor in neuronal nitric oxide synthase (nNOS), and 4-aminotetrahydrobiopterin (4-amino-H 4 B), an inhibitor of nNOS, using computer-assisted molecular modeling techniques. Molecular modeling, superimposing, and docking simulation, in addition to LUMO-energy calculation, revealed that genipin has structural and electronic properties that markedly resemble those of H 4 B.
INTRODUCTION
Iridoid compounds are known to possess various biological activities, such as antimicrobial, 1) anticancer, 2) hemodynamic, 3) choleretic, 4) and hepatoprotective effects. 5) In previous studies, we have shown that iridoid compounds, such as geniposide, gardenoside, catalpol, aucubin, and their aglycones, have neuritogenic activity in PC12 h cells, 6) which are a subclone of rat pheochromocytoma cells. 7) Genipin, the aglycon of geniposide, is a particularly potent inducer of neurite outgrowth. Our subsequent investigations of this series have shown that genipin also increased survival in Neuro2a cells, a neuronal cell line, exposed to serum deprivationinduced cytotoxicity, 8) and markedly induced neurite outgrowth through a nitric oxide synthase (NOS)-guanosine 3 ,5 -cyclic monophosphate dependent protein kinase pathway followed by extracellular signal-regulated kinase (ERK) activation in rat pheochromocytoma PC12 h cells. 9, 10) It is possible that neuronal NOS (nNOS) is the target molecule for the neuritogenic action of genipin. Therefore, we hypothesized that genipin may directly bind to and activate nNOS, as well as possess * To whom correspondence should be addressed: Department of Biochemistry, Faculty of Pharmaceutical Sciences, Hokuriku University, Ho-3 Kanagawa-machi, Kanazawa, Ishikawa 920-1181, Japan. Tel.: +81-076-229-1165; Fax: +81-076-229-2781; E-mail: k-chiba@hokuriku-u.ac.jp neurotrophic factor-like activity, similar to that of nerve growth factor or other neurotrophins. 11) As we were interested in studying the characteristic properties of genipin as an activator of nNOS, the present investigation was undertaken to compare the structural and electronic properties of genipin with those of tetrahydrobiopterin (H 4 B) and 4-aminotetrahydrobiopterin (4-amino-H 4 B) using computer-assisted molecular modeling techniques ( Fig. 1 ).
MATERIALS AND METHODS
Calculations of molecular orbital and molecular electrostatic potentials were performed using the PM5 method of the MOPAC program. Construction of the molecules, superimposition, and docking simulation were performed using a Scigress Explorer ver. 7.5 parameter set developed by Fujitsu Co. (Chiba, Japan). X-ray crystallographic data for H 4 B and 4-amino-H 4 B in complex nNOS were obtained from Protein Data Bank ID: 1QW6. 12) 6 position), as shown in Fig. 2 . Molecular superimpositions upon the three computer-generated lowest energy conformers were generated by fitting each conformer. The fit of genipin to H 4 B in its pharmacophoric conformation gave a root mean square fit of 0.3 Å and that of H 4 B to 4-amino-H 4 B gave a root mean square fit of 0 Å (Fig. 3) . Molecular modeling and superimposing experiments showed that genipin was structurally very similar to H 4 B and 4-amino-H 4 B, indicating a close degree of overlap in their pharmacophoric conformations.
Docking Simulation of Genipin and H 4 B with nNOS
Each crystal structure of H 4 B and 4-amino-H 4 B in complex nNOS revealed the location of both binding sites of nNOS. 13) Figure 4 (a) shows x-ray crystallographic data for H 4 B in complex nNOS. Adopting this conformation, genipin was computer docked inside the H 4 B binding site of nNOS [ Fig. 4(b) ]. The results indicated that the ester carbonyl oxygen at the 4 position of genipin and the Arg 596 main chain nitrogen in nNOS were located within a hydrogen-bond distance of 2.1 Å.
Electronic Features of Genipin, H 4 B, 4-amino-H 4 B, and Some nNOS Inhibitors (N ω -propyl-LAlg, W1400, AR-R17477)
It is interesting that genipin and H 4 B act as nNOS activators, while 4-amino-H 4 B acts as an nNOS inhibitor, even though these compounds were found to have marked structural similarities in the above experimental data. Thus, calculations of the HOMO-and LUMO-energy of genipin, H 4 B and 4-amino-H 4 B, in addition to some known nNOS inhibitors (N ω -propyl-L-Alg, W1400, AR-R17477), were carried out using the PM5 method in the MOPAC program (Table 1) . A plot of the HOMOenergy versus the LUMO-energy for these compounds is shown in Fig. 5 . These compounds were classified into inhibitors and activators in nNOS, according to whether their LUMO-energy was above or below −0.3 eV, even though the characteristics of their HOMO-energy were not unique. This result supports the possibility that genipin and H 4 B may interact with a more electronegative receptor binding site than do 4-amino-H 4 B and other known NOS inhibitors. Molecular modeling, superimposing, and docking experiments, in addition to the calculation of LUMO-energy, were performed to characterize the properties of genipin. It was revealed that genipin has structural and electronic properties that closely resemble those of H 4 B. We hope to be able to apply the insights gleaned from these studies to design new nNOS activators possessing strong affinity and potent activity.
